Presentation
5 March 2021 Preliminary clinical study of the potential of multi-modal optical/ultrasound LUCA platform for improved thyroid cancer screening
Author Affiliations +
Abstract
The LUCA device combines clinical ultrasound, time-domain near infrared and diffuse correlation spectroscopies with the aim of improving thyroid cancer screening sensitivity and specificity. The preliminary clinical campaign on patients (n=31) with thyroid nodules and healthy controls (n=11) allowed the characterization of the precision of the instrument and demonstrated that using a couple of biomarkers the muscle-to-nodule contrast allows an area under the curve of 0.92 for single-nodule patients and 0.77 for all patients in differentiating benign and malignant nodules in a receiver operating characteristic curve. We will present the updated results from the ongoing study.
Conference Presentation
© (2021) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Lorenzo Cortese, Giuseppe Lo Presti, Pablo Fernandez Esteberena, Marta Zanoletti, Mauro Buttafava, Marco Renna, Davide Contini, Alberto Dalla Mora, Antonio Pifferi, Paola Taroni, Alberto Tosi, Gloria Aranda, Sabina Ruiz Janer, Mattia Squarcia, Felicia Hanzu, Mireia Mora Porta, Stanislaw Wojtkiewicz, Hamid Dehghani, Udo M. Weigel, Sixte de Fraguier, An Nguyen-Dinh, Bogdan Rosinski, and Turgut Durduran "Preliminary clinical study of the potential of multi-modal optical/ultrasound LUCA platform for improved thyroid cancer screening", Proc. SPIE 11639, Optical Tomography and Spectroscopy of Tissue XIV, 116390L (5 March 2021); https://doi.org/10.1117/12.2577248
Advertisement
Advertisement
Back to Top